avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hey1
|
ENSMUSG00000040289.3 | hairy/enhancer-of-split related with YRPW motif 1 |
Myc
|
ENSMUSG00000022346.8 | myelocytomatosis oncogene |
Mxi1
|
ENSMUSG00000025025.7 | MAX interactor 1, dimerization protein |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Myc | mm10_v2_chr15_+_61987410_61987491 | 0.55 | 5.3e-04 | Click! |
Mxi1 | mm10_v2_chr19_+_53310495_53310552 | 0.51 | 1.7e-03 | Click! |
Hey1 | mm10_v2_chr3_-_8667033_8667046 | 0.09 | 5.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_26199008 | 7.10 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
Pdia2
|
protein disulfide isomerase associated 2 |
chr11_+_69095217 | 5.49 |
ENSMUST00000101004.2
|
Per1
|
period circadian clock 1 |
chr17_-_26201363 | 4.50 |
ENSMUST00000121959.1
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr9_-_67832325 | 3.91 |
ENSMUST00000054500.5
|
C2cd4a
|
C2 calcium-dependent domain containing 4A |
chr6_-_70792155 | 3.60 |
ENSMUST00000066134.5
|
Rpia
|
ribose 5-phosphate isomerase A |
chr18_+_35553401 | 3.32 |
ENSMUST00000181664.1
|
Snhg4
|
small nucleolar RNA host gene 4 (non-protein coding) |
chr19_+_10018193 | 3.27 |
ENSMUST00000113161.2
ENSMUST00000117641.1 |
Rab3il1
|
RAB3A interacting protein (rabin3)-like 1 |
chrX_+_8271133 | 3.25 |
ENSMUST00000127103.1
ENSMUST00000115591.1 |
Slc38a5
|
solute carrier family 38, member 5 |
chrX_+_8271381 | 3.24 |
ENSMUST00000033512.4
|
Slc38a5
|
solute carrier family 38, member 5 |
chr19_+_10018265 | 3.11 |
ENSMUST00000131407.1
|
Rab3il1
|
RAB3A interacting protein (rabin3)-like 1 |
chr12_+_109459843 | 3.09 |
ENSMUST00000173812.1
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chrX_-_136068236 | 3.08 |
ENSMUST00000049130.7
|
Bex2
|
brain expressed X-linked 2 |
chrX_-_136215443 | 2.97 |
ENSMUST00000113120.1
ENSMUST00000113118.1 ENSMUST00000058125.8 |
Bex1
|
brain expressed gene 1 |
chr2_+_129198757 | 2.84 |
ENSMUST00000028880.3
|
Slc20a1
|
solute carrier family 20, member 1 |
chrX_+_8271642 | 2.81 |
ENSMUST00000115590.1
|
Slc38a5
|
solute carrier family 38, member 5 |
chr11_-_96005872 | 2.78 |
ENSMUST00000013559.2
|
Igf2bp1
|
insulin-like growth factor 2 mRNA binding protein 1 |
chrX_+_73639414 | 2.77 |
ENSMUST00000019701.8
|
Dusp9
|
dual specificity phosphatase 9 |
chr14_-_89898466 | 2.72 |
ENSMUST00000081204.4
|
Gm10110
|
predicted gene 10110 |
chr7_+_24370255 | 2.70 |
ENSMUST00000171904.1
|
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr2_+_164769892 | 2.68 |
ENSMUST00000088248.6
ENSMUST00000001439.6 |
Ube2c
|
ubiquitin-conjugating enzyme E2C |
chr2_-_35979624 | 2.64 |
ENSMUST00000028248.4
ENSMUST00000112976.2 |
Ttll11
|
tubulin tyrosine ligase-like family, member 11 |
chr17_-_26201328 | 2.61 |
ENSMUST00000025019.2
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr5_+_66676098 | 2.60 |
ENSMUST00000031131.9
|
Uchl1
|
ubiquitin carboxy-terminal hydrolase L1 |
chr17_-_24658425 | 2.52 |
ENSMUST00000095544.4
|
Npw
|
neuropeptide W |
chr7_-_44986313 | 2.47 |
ENSMUST00000045325.6
ENSMUST00000085387.4 ENSMUST00000107840.1 ENSMUST00000107843.3 ENSMUST00000107842.3 |
Prmt1
|
protein arginine N-methyltransferase 1 |
chr9_+_107587711 | 2.39 |
ENSMUST00000010192.5
|
Ifrd2
|
interferon-related developmental regulator 2 |
chr2_+_91035613 | 2.37 |
ENSMUST00000111445.3
ENSMUST00000111446.3 ENSMUST00000050323.5 |
Rapsn
|
receptor-associated protein of the synapse |
chr11_+_101316200 | 2.32 |
ENSMUST00000142640.1
ENSMUST00000019470.7 |
Psme3
|
proteaseome (prosome, macropain) activator subunit 3 (PA28 gamma, Ki) |
chr3_-_95882193 | 2.29 |
ENSMUST00000159863.1
ENSMUST00000159739.1 ENSMUST00000036418.3 |
Gm129
|
predicted gene 129 |
chr7_-_133123770 | 2.28 |
ENSMUST00000164896.1
ENSMUST00000171968.1 |
Ctbp2
|
C-terminal binding protein 2 |
chr15_-_77956658 | 2.25 |
ENSMUST00000117725.1
ENSMUST00000016696.6 |
Foxred2
|
FAD-dependent oxidoreductase domain containing 2 |
chr8_-_122551316 | 2.22 |
ENSMUST00000067252.7
|
Piezo1
|
piezo-type mechanosensitive ion channel component 1 |
chr4_-_155992604 | 2.20 |
ENSMUST00000052185.3
|
B3galt6
|
UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6 |
chr3_+_28781305 | 2.18 |
ENSMUST00000060500.7
|
Eif5a2
|
eukaryotic translation initiation factor 5A2 |
chr11_+_116198853 | 2.16 |
ENSMUST00000021130.6
|
Ten1
|
TEN1 telomerase capping complex subunit |
chr11_-_12026237 | 2.15 |
ENSMUST00000150972.1
|
Grb10
|
growth factor receptor bound protein 10 |
chr12_+_17544873 | 2.15 |
ENSMUST00000171737.1
|
Odc1
|
ornithine decarboxylase, structural 1 |
chr19_+_54045182 | 2.14 |
ENSMUST00000036700.5
|
Adra2a
|
adrenergic receptor, alpha 2a |
chr2_+_127336152 | 2.13 |
ENSMUST00000028846.6
|
Dusp2
|
dual specificity phosphatase 2 |
chr13_+_112288451 | 2.06 |
ENSMUST00000022275.6
ENSMUST00000056047.7 ENSMUST00000165593.1 |
Ankrd55
|
ankyrin repeat domain 55 |
chr2_+_155611175 | 2.06 |
ENSMUST00000092995.5
|
Myh7b
|
myosin, heavy chain 7B, cardiac muscle, beta |
chr5_-_148995147 | 2.04 |
ENSMUST00000147473.1
|
Katnal1
|
katanin p60 subunit A-like 1 |
chrX_+_136138996 | 1.96 |
ENSMUST00000116527.1
|
Bex4
|
brain expressed gene 4 |
chr1_-_75142360 | 1.93 |
ENSMUST00000041213.5
|
Cnppd1
|
cyclin Pas1/PHO80 domain containing 1 |
chr10_+_13090788 | 1.92 |
ENSMUST00000121646.1
ENSMUST00000121325.1 ENSMUST00000121766.1 |
Plagl1
|
pleiomorphic adenoma gene-like 1 |
chr1_-_128592284 | 1.91 |
ENSMUST00000052172.6
ENSMUST00000142893.1 |
Cxcr4
|
chemokine (C-X-C motif) receptor 4 |
chr11_-_12026732 | 1.91 |
ENSMUST00000143915.1
|
Grb10
|
growth factor receptor bound protein 10 |
chr3_-_95882232 | 1.90 |
ENSMUST00000161866.1
|
Gm129
|
predicted gene 129 |
chr9_-_42124276 | 1.90 |
ENSMUST00000060989.8
|
Sorl1
|
sortilin-related receptor, LDLR class A repeats-containing |
chr9_-_114781986 | 1.87 |
ENSMUST00000035009.8
ENSMUST00000084867.7 |
Cmtm7
|
CKLF-like MARVEL transmembrane domain containing 7 |
chr6_+_148047259 | 1.84 |
ENSMUST00000032443.7
|
Far2
|
fatty acyl CoA reductase 2 |
chr7_+_19577287 | 1.83 |
ENSMUST00000108453.1
|
Zfp296
|
zinc finger protein 296 |
chr11_+_87755567 | 1.83 |
ENSMUST00000123700.1
|
A430104N18Rik
|
RIKEN cDNA A430104N18 gene |
chr2_+_84840612 | 1.81 |
ENSMUST00000111625.1
|
Slc43a1
|
solute carrier family 43, member 1 |
chr11_-_54028090 | 1.78 |
ENSMUST00000020586.6
|
Slc22a4
|
solute carrier family 22 (organic cation transporter), member 4 |
chr2_+_30286383 | 1.74 |
ENSMUST00000064447.5
|
Nup188
|
nucleoporin 188 |
chr13_+_112288516 | 1.72 |
ENSMUST00000168684.1
|
Ankrd55
|
ankyrin repeat domain 55 |
chr4_-_140774196 | 1.69 |
ENSMUST00000026381.6
|
Padi4
|
peptidyl arginine deiminase, type IV |
chr6_-_131388417 | 1.69 |
ENSMUST00000032309.6
ENSMUST00000087865.2 |
Ybx3
|
Y box protein 3 |
chr8_+_123117354 | 1.65 |
ENSMUST00000037900.8
|
Cpne7
|
copine VII |
chr6_-_52226165 | 1.61 |
ENSMUST00000114425.2
|
Hoxa9
|
homeobox A9 |
chr19_+_6975048 | 1.58 |
ENSMUST00000070850.6
|
Ppp1r14b
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr9_-_103761820 | 1.57 |
ENSMUST00000049452.8
|
Tmem108
|
transmembrane protein 108 |
chr4_+_138250462 | 1.53 |
ENSMUST00000105823.1
|
Sh2d5
|
SH2 domain containing 5 |
chrX_-_101085352 | 1.51 |
ENSMUST00000101362.1
ENSMUST00000073927.4 |
Slc7a3
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 |
chr5_-_103629279 | 1.50 |
ENSMUST00000031263.1
|
Slc10a6
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 6 |
chr11_+_11684967 | 1.49 |
ENSMUST00000126058.1
ENSMUST00000141436.1 |
Ikzf1
|
IKAROS family zinc finger 1 |
chr7_+_108934405 | 1.49 |
ENSMUST00000033342.6
|
Eif3f
|
eukaryotic translation initiation factor 3, subunit F |
chr2_+_84839395 | 1.47 |
ENSMUST00000146816.1
ENSMUST00000028469.7 |
Slc43a1
|
solute carrier family 43, member 1 |
chr12_-_32061221 | 1.47 |
ENSMUST00000003079.5
ENSMUST00000036497.9 |
Prkar2b
|
protein kinase, cAMP dependent regulatory, type II beta |
chr7_-_126799134 | 1.47 |
ENSMUST00000087566.4
|
Aldoa
|
aldolase A, fructose-bisphosphate |
chr8_+_105690906 | 1.46 |
ENSMUST00000062574.6
|
Rltpr
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
chr9_+_21368014 | 1.45 |
ENSMUST00000067646.4
ENSMUST00000115414.1 |
Ilf3
|
interleukin enhancer binding factor 3 |
chr4_-_43046196 | 1.45 |
ENSMUST00000036462.5
|
Fam214b
|
family with sequence similarity 214, member B |
chr8_+_88272403 | 1.44 |
ENSMUST00000169037.1
|
Adcy7
|
adenylate cyclase 7 |
chr19_-_4615453 | 1.43 |
ENSMUST00000053597.2
|
Lrfn4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr10_-_81001338 | 1.43 |
ENSMUST00000099462.1
ENSMUST00000118233.1 |
Gng7
|
guanine nucleotide binding protein (G protein), gamma 7 |
chr4_+_148591482 | 1.41 |
ENSMUST00000006611.8
|
Srm
|
spermidine synthase |
chr6_-_38299236 | 1.41 |
ENSMUST00000058524.2
|
Zc3hav1l
|
zinc finger CCCH-type, antiviral 1-like |
chr2_-_58160495 | 1.39 |
ENSMUST00000028175.6
|
Cytip
|
cytohesin 1 interacting protein |
chr4_-_43045686 | 1.38 |
ENSMUST00000107956.1
ENSMUST00000107957.1 |
Fam214b
|
family with sequence similarity 214, member B |
chr1_+_63176818 | 1.37 |
ENSMUST00000129339.1
|
Eef1b2
|
eukaryotic translation elongation factor 1 beta 2 |
chr11_+_3332426 | 1.37 |
ENSMUST00000136474.1
|
Pik3ip1
|
phosphoinositide-3-kinase interacting protein 1 |
chr11_-_117780630 | 1.37 |
ENSMUST00000026659.3
ENSMUST00000127227.1 |
Tmc6
|
transmembrane channel-like gene family 6 |
chr7_-_126799163 | 1.37 |
ENSMUST00000032934.5
|
Aldoa
|
aldolase A, fructose-bisphosphate |
chr19_-_41848076 | 1.35 |
ENSMUST00000059231.2
|
Frat2
|
frequently rearranged in advanced T cell lymphomas 2 |
chr2_+_130274424 | 1.35 |
ENSMUST00000103198.4
|
Nop56
|
NOP56 ribonucleoprotein |
chr19_-_40588453 | 1.35 |
ENSMUST00000025979.6
|
Aldh18a1
|
aldehyde dehydrogenase 18 family, member A1 |
chr6_-_52217505 | 1.34 |
ENSMUST00000048715.6
|
Hoxa7
|
homeobox A7 |
chr17_+_48359891 | 1.33 |
ENSMUST00000024792.6
|
Treml1
|
triggering receptor expressed on myeloid cells-like 1 |
chr4_-_129742275 | 1.33 |
ENSMUST00000066257.5
|
Khdrbs1
|
KH domain containing, RNA binding, signal transduction associated 1 |
chr11_-_120348513 | 1.32 |
ENSMUST00000071555.6
|
Actg1
|
actin, gamma, cytoplasmic 1 |
chr5_+_76840597 | 1.32 |
ENSMUST00000120639.2
ENSMUST00000163347.1 ENSMUST00000121851.1 |
C530008M17Rik
|
RIKEN cDNA C530008M17 gene |
chr4_+_32657107 | 1.32 |
ENSMUST00000071642.4
ENSMUST00000178134.1 |
Mdn1
|
midasin homolog (yeast) |
chr11_+_69098937 | 1.32 |
ENSMUST00000021271.7
|
Per1
|
period circadian clock 1 |
chr2_-_102451792 | 1.31 |
ENSMUST00000099678.3
|
Fjx1
|
four jointed box 1 (Drosophila) |
chr19_-_4615647 | 1.31 |
ENSMUST00000113822.2
|
Lrfn4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr4_+_11191354 | 1.29 |
ENSMUST00000170901.1
|
Ccne2
|
cyclin E2 |
chr4_+_63558748 | 1.29 |
ENSMUST00000077709.4
|
6330416G13Rik
|
RIKEN cDNA 6330416G13 gene |
chr2_+_130274437 | 1.29 |
ENSMUST00000141872.1
|
Nop56
|
NOP56 ribonucleoprotein |
chr17_+_47611570 | 1.28 |
ENSMUST00000024778.2
|
Med20
|
mediator complex subunit 20 |
chr2_-_181693810 | 1.28 |
ENSMUST00000108776.1
ENSMUST00000108771.1 ENSMUST00000108779.1 ENSMUST00000108769.1 ENSMUST00000108772.1 ENSMUST00000002532.2 |
Rgs19
|
regulator of G-protein signaling 19 |
chr11_-_96943945 | 1.28 |
ENSMUST00000107629.1
ENSMUST00000018803.5 |
Pnpo
|
pyridoxine 5'-phosphate oxidase |
chr19_-_40588338 | 1.27 |
ENSMUST00000176939.1
|
Aldh18a1
|
aldehyde dehydrogenase 18 family, member A1 |
chr3_-_90052463 | 1.27 |
ENSMUST00000029553.9
ENSMUST00000064639.8 ENSMUST00000090908.6 |
Ubap2l
|
ubiquitin associated protein 2-like |
chr19_-_10203880 | 1.27 |
ENSMUST00000142241.1
ENSMUST00000116542.2 ENSMUST00000025651.5 ENSMUST00000156291.1 |
Fen1
|
flap structure specific endonuclease 1 |
chr2_+_105126505 | 1.24 |
ENSMUST00000143043.1
|
Wt1
|
Wilms tumor 1 homolog |
chr5_+_138280516 | 1.22 |
ENSMUST00000048028.8
|
Stag3
|
stromal antigen 3 |
chr1_-_193035651 | 1.22 |
ENSMUST00000016344.7
|
Syt14
|
synaptotagmin XIV |
chr19_-_24555819 | 1.22 |
ENSMUST00000112673.2
ENSMUST00000025800.8 |
Pip5k1b
|
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
chr2_+_30286406 | 1.21 |
ENSMUST00000138666.1
ENSMUST00000113634.2 |
Nup188
|
nucleoporin 188 |
chr5_+_146948640 | 1.21 |
ENSMUST00000146511.1
ENSMUST00000132102.1 |
Gtf3a
|
general transcription factor III A |
chr2_+_156840966 | 1.20 |
ENSMUST00000109564.1
|
Tgif2
|
TGFB-induced factor homeobox 2 |
chr7_+_24884809 | 1.20 |
ENSMUST00000156372.1
ENSMUST00000124035.1 |
Rps19
|
ribosomal protein S19 |
chr11_+_116531744 | 1.20 |
ENSMUST00000106387.2
ENSMUST00000100201.3 |
Sphk1
|
sphingosine kinase 1 |
chr5_+_139791513 | 1.19 |
ENSMUST00000018287.3
|
Mafk
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
chr11_+_32286946 | 1.17 |
ENSMUST00000101387.3
|
Hbq1b
|
hemoglobin, theta 1B |
chr17_-_47611449 | 1.16 |
ENSMUST00000024783.8
|
Bysl
|
bystin-like |
chr10_+_127063599 | 1.15 |
ENSMUST00000120226.1
ENSMUST00000133115.1 |
Cdk4
|
cyclin-dependent kinase 4 |
chr3_-_37724321 | 1.15 |
ENSMUST00000108105.1
ENSMUST00000079755.4 ENSMUST00000099128.1 |
Gm5148
|
predicted gene 5148 |
chr19_-_40588374 | 1.15 |
ENSMUST00000175932.1
ENSMUST00000176955.1 ENSMUST00000149476.2 |
Aldh18a1
|
aldehyde dehydrogenase 18 family, member A1 |
chr11_+_61684419 | 1.15 |
ENSMUST00000093019.5
|
Fam83g
|
family with sequence similarity 83, member G |
chr2_+_128126030 | 1.14 |
ENSMUST00000089634.5
ENSMUST00000019281.7 ENSMUST00000110341.2 ENSMUST00000103211.1 ENSMUST00000103210.1 |
Bcl2l11
|
BCL2-like 11 (apoptosis facilitator) |
chr9_-_107289847 | 1.14 |
ENSMUST00000035194.2
|
Mapkapk3
|
mitogen-activated protein kinase-activated protein kinase 3 |
chr2_-_163087770 | 1.14 |
ENSMUST00000094653.4
|
Gtsf1l
|
gametocyte specific factor 1-like |
chr13_+_90923122 | 1.11 |
ENSMUST00000051955.7
|
Rps23
|
ribosomal protein S23 |
chr2_-_92370999 | 1.10 |
ENSMUST00000176810.1
ENSMUST00000090582.4 |
Gyltl1b
|
glycosyltransferase-like 1B |
chr5_+_122100951 | 1.10 |
ENSMUST00000014080.6
ENSMUST00000111750.1 ENSMUST00000139213.1 ENSMUST00000111751.1 ENSMUST00000155612.1 |
Myl2
|
myosin, light polypeptide 2, regulatory, cardiac, slow |
chr11_+_102189620 | 1.10 |
ENSMUST00000070334.3
ENSMUST00000078975.7 |
G6pc3
|
glucose 6 phosphatase, catalytic, 3 |
chr19_+_59322287 | 1.10 |
ENSMUST00000086764.5
|
Rps12-ps3
|
ribosomal protein S12, pseudogene 3 |
chrX_+_48146436 | 1.09 |
ENSMUST00000033427.6
|
Sash3
|
SAM and SH3 domain containing 3 |
chr11_+_98383811 | 1.09 |
ENSMUST00000008021.2
|
Tcap
|
titin-cap |
chr4_-_134018829 | 1.09 |
ENSMUST00000051674.2
|
Lin28a
|
lin-28 homolog A (C. elegans) |
chr3_-_129831374 | 1.08 |
ENSMUST00000029643.8
|
Gar1
|
GAR1 ribonucleoprotein homolog (yeast) |
chr10_+_80930071 | 1.07 |
ENSMUST00000015456.8
|
Gadd45b
|
growth arrest and DNA-damage-inducible 45 beta |
chr11_+_114727384 | 1.07 |
ENSMUST00000069325.7
|
Dnaic2
|
dynein, axonemal, intermediate chain 2 |
chr12_-_76962178 | 1.07 |
ENSMUST00000110395.3
ENSMUST00000082136.5 |
Max
|
Max protein |
chr2_-_92371039 | 1.06 |
ENSMUST00000068586.6
|
Gyltl1b
|
glycosyltransferase-like 1B |
chr7_-_45466894 | 1.06 |
ENSMUST00000033093.8
|
Bax
|
BCL2-associated X protein |
chrX_-_9256899 | 1.03 |
ENSMUST00000115553.2
|
Gm14862
|
predicted gene 14862 |
chr5_-_135251209 | 1.03 |
ENSMUST00000062572.2
|
Fzd9
|
frizzled homolog 9 (Drosophila) |
chr5_-_138279960 | 1.03 |
ENSMUST00000014089.7
ENSMUST00000161827.1 |
Gpc2
|
glypican 2 (cerebroglycan) |
chr17_+_56040350 | 1.03 |
ENSMUST00000002914.8
|
Chaf1a
|
chromatin assembly factor 1, subunit A (p150) |
chr11_-_84819450 | 1.03 |
ENSMUST00000018549.7
|
Mrm1
|
mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae) |
chr16_+_32608973 | 1.02 |
ENSMUST00000120680.1
|
Tfrc
|
transferrin receptor |
chrX_+_159627265 | 1.02 |
ENSMUST00000112456.2
|
Sh3kbp1
|
SH3-domain kinase binding protein 1 |
chr17_-_29237759 | 1.01 |
ENSMUST00000137727.1
ENSMUST00000024805.7 |
Cpne5
|
copine V |
chr5_-_113830422 | 1.01 |
ENSMUST00000100874.4
|
Selplg
|
selectin, platelet (p-selectin) ligand |
chr7_-_28981787 | 1.00 |
ENSMUST00000066070.5
|
Eif3k
|
eukaryotic translation initiation factor 3, subunit K |
chr2_+_164074122 | 0.99 |
ENSMUST00000018353.7
|
Stk4
|
serine/threonine kinase 4 |
chr16_+_35770382 | 0.99 |
ENSMUST00000023555.4
|
Hspbap1
|
Hspb associated protein 1 |
chr17_+_35000987 | 0.99 |
ENSMUST00000087315.7
ENSMUST00000173584.1 |
Vars
|
valyl-tRNA synthetase |
chr7_-_35396708 | 0.98 |
ENSMUST00000154597.1
ENSMUST00000032704.5 |
C230052I12Rik
|
RIKEN cDNA C230052I12 gene |
chr1_+_59684949 | 0.98 |
ENSMUST00000027174.3
|
Nop58
|
NOP58 ribonucleoprotein |
chr8_-_92356103 | 0.97 |
ENSMUST00000034183.3
|
4933436C20Rik
|
RIKEN cDNA 4933436C20 gene |
chrX_-_8145679 | 0.94 |
ENSMUST00000115619.1
ENSMUST00000115617.3 ENSMUST00000040010.3 |
Rbm3
|
RNA binding motif protein 3 |
chr9_-_14381242 | 0.94 |
ENSMUST00000167549.1
|
Endod1
|
endonuclease domain containing 1 |
chr6_+_4755327 | 0.94 |
ENSMUST00000176551.1
|
Peg10
|
paternally expressed 10 |
chr2_-_131160006 | 0.93 |
ENSMUST00000103188.3
ENSMUST00000133602.1 ENSMUST00000028800.5 |
1700037H04Rik
|
RIKEN cDNA 1700037H04 gene |
chr11_-_82908360 | 0.93 |
ENSMUST00000103213.3
|
Nle1
|
notchless homolog 1 (Drosophila) |
chr8_+_75093591 | 0.93 |
ENSMUST00000005548.6
|
Hmox1
|
heme oxygenase (decycling) 1 |
chr2_+_152143552 | 0.93 |
ENSMUST00000089112.5
|
Tcf15
|
transcription factor 15 |
chr7_-_126949499 | 0.93 |
ENSMUST00000106339.1
ENSMUST00000052937.5 |
Asphd1
|
aspartate beta-hydroxylase domain containing 1 |
chr2_+_150570409 | 0.93 |
ENSMUST00000089200.2
|
Cst7
|
cystatin F (leukocystatin) |
chr3_-_95882031 | 0.93 |
ENSMUST00000161994.1
|
Gm129
|
predicted gene 129 |
chr10_+_80016653 | 0.93 |
ENSMUST00000099501.3
|
Hmha1
|
histocompatibility (minor) HA-1 |
chr17_+_43016536 | 0.91 |
ENSMUST00000024708.4
|
Tnfrsf21
|
tumor necrosis factor receptor superfamily, member 21 |
chr10_+_80016901 | 0.91 |
ENSMUST00000105373.1
|
Hmha1
|
histocompatibility (minor) HA-1 |
chr10_-_45470201 | 0.91 |
ENSMUST00000079390.6
|
Lin28b
|
lin-28 homolog B (C. elegans) |
chr11_-_97782409 | 0.91 |
ENSMUST00000103146.4
|
Rpl23
|
ribosomal protein L23 |
chr7_+_24884651 | 0.90 |
ENSMUST00000153451.2
ENSMUST00000108429.1 |
Rps19
|
ribosomal protein S19 |
chr17_+_35001282 | 0.90 |
ENSMUST00000174260.1
|
Vars
|
valyl-tRNA synthetase |
chr7_+_28693032 | 0.90 |
ENSMUST00000151227.1
ENSMUST00000108281.1 |
Fbxo27
|
F-box protein 27 |
chr3_-_108226598 | 0.90 |
ENSMUST00000029486.7
ENSMUST00000156371.1 ENSMUST00000141387.1 |
Sypl2
|
synaptophysin-like 2 |
chr17_-_28080567 | 0.89 |
ENSMUST00000114836.1
ENSMUST00000042692.5 |
Tcp11
|
t-complex protein 11 |
chr11_-_120348475 | 0.89 |
ENSMUST00000062147.7
ENSMUST00000128055.1 |
Actg1
|
actin, gamma, cytoplasmic 1 |
chr12_-_17176888 | 0.89 |
ENSMUST00000170580.1
|
Kcnf1
|
potassium voltage-gated channel, subfamily F, member 1 |
chr15_+_103240405 | 0.89 |
ENSMUST00000036004.9
ENSMUST00000087351.7 |
Hnrnpa1
|
heterogeneous nuclear ribonucleoprotein A1 |
chr11_-_97782377 | 0.89 |
ENSMUST00000128801.1
|
Rpl23
|
ribosomal protein L23 |
chr11_-_52000748 | 0.89 |
ENSMUST00000109086.1
|
Ube2b
|
ubiquitin-conjugating enzyme E2B |
chr11_-_76217490 | 0.88 |
ENSMUST00000102500.4
|
Gemin4
|
gem (nuclear organelle) associated protein 4 |
chr5_-_136170634 | 0.88 |
ENSMUST00000041048.1
|
Orai2
|
ORAI calcium release-activated calcium modulator 2 |
chr17_-_35000746 | 0.88 |
ENSMUST00000163360.1
|
D17H6S56E-5
|
DNA segment, Chr 17, human D6S56E 5 |
chr16_-_57606816 | 0.88 |
ENSMUST00000114371.3
|
Cmss1
|
cms small ribosomal subunit 1 |
chr17_-_66077022 | 0.88 |
ENSMUST00000150766.1
ENSMUST00000038116.5 |
Ankrd12
|
ankyrin repeat domain 12 |
chr17_-_28080595 | 0.87 |
ENSMUST00000141806.1
ENSMUST00000043925.8 ENSMUST00000129046.1 |
Tcp11
|
t-complex protein 11 |
chr7_+_60155538 | 0.87 |
ENSMUST00000057611.4
|
Gm7367
|
predicted pseudogene 7367 |
chr3_+_88532314 | 0.87 |
ENSMUST00000172699.1
|
Mex3a
|
mex3 homolog A (C. elegans) |
chr7_-_16286744 | 0.87 |
ENSMUST00000150528.2
ENSMUST00000118976.2 ENSMUST00000146609.2 |
Ccdc9
|
coiled-coil domain containing 9 |
chr7_+_99535652 | 0.87 |
ENSMUST00000032995.8
ENSMUST00000162404.1 |
Arrb1
|
arrestin, beta 1 |
chr3_-_116253467 | 0.87 |
ENSMUST00000090473.5
|
Gpr88
|
G-protein coupled receptor 88 |
chr13_+_108316332 | 0.86 |
ENSMUST00000051594.5
|
Depdc1b
|
DEP domain containing 1B |
chr11_+_3289880 | 0.85 |
ENSMUST00000110043.1
ENSMUST00000094471.3 |
Patz1
|
POZ (BTB) and AT hook containing zinc finger 1 |
chr14_-_70443219 | 0.85 |
ENSMUST00000180358.1
|
Polr3d
|
polymerase (RNA) III (DNA directed) polypeptide D |
chr5_+_138280538 | 0.85 |
ENSMUST00000162245.1
ENSMUST00000161691.1 |
Stag3
|
stromal antigen 3 |
chr11_+_101316917 | 0.85 |
ENSMUST00000151385.1
|
Psme3
|
proteaseome (prosome, macropain) activator subunit 3 (PA28 gamma, Ki) |
chr6_+_125131869 | 0.84 |
ENSMUST00000044200.8
|
Nop2
|
NOP2 nucleolar protein |
chrX_+_135993820 | 0.84 |
ENSMUST00000058119.7
|
Arxes2
|
adipocyte-related X-chromosome expressed sequence 2 |
chr16_+_5050012 | 0.82 |
ENSMUST00000052449.5
|
Ubn1
|
ubinuclein 1 |
chr16_+_94085226 | 0.82 |
ENSMUST00000072182.7
|
Sim2
|
single-minded homolog 2 (Drosophila) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 7.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.3 | 3.8 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.9 | 3.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.7 | 3.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.7 | 2.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.7 | 2.2 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.7 | 2.9 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.7 | 2.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.6 | 1.9 | GO:2001074 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.6 | 2.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.6 | 4.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.6 | 2.3 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.6 | 2.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.6 | 2.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.5 | 2.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.5 | 9.1 | GO:0015816 | glycine transport(GO:0015816) |
0.5 | 0.5 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
0.5 | 2.5 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.5 | 1.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.5 | 1.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 1.4 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.5 | 2.8 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.5 | 1.8 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 2.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 1.3 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.4 | 2.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.4 | 0.4 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
0.4 | 4.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.4 | 2.2 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.4 | 1.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 1.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 1.0 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
0.3 | 1.0 | GO:1990523 | bone regeneration(GO:1990523) |
0.3 | 1.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.3 | 1.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.3 | 1.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 0.9 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 1.8 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 2.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 2.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 1.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.7 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 1.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.7 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.2 | 1.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.2 | 2.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 3.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 1.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.2 | 1.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 0.2 | GO:1903632 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.2 | 1.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 0.6 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.2 | 2.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.8 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.2 | 1.0 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 0.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 1.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.7 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.2 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 1.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 1.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.2 | 1.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 1.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 2.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.5 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
0.2 | 6.8 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.2 | 1.4 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.2 | 1.8 | GO:0015879 | carnitine transport(GO:0015879) |
0.2 | 3.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 1.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 1.1 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 2.2 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.2 | 2.6 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.2 | 0.7 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.8 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.2 | 1.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.2 | 0.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 2.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 1.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 1.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.2 | 0.6 | GO:0021586 | pons maturation(GO:0021586) |
0.2 | 0.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.5 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.2 | 0.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.5 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.2 | 0.5 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
0.2 | 0.8 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 1.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.4 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.1 | 3.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 4.3 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.4 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.6 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.6 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.1 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 2.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.5 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.1 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.4 | GO:0009826 | unidimensional cell growth(GO:0009826) establishment or maintenance of cell polarity regulating cell shape(GO:0071963) regulation of barbed-end actin filament capping(GO:2000812) |
0.1 | 0.5 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.1 | 0.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 2.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.8 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.4 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.1 | 0.2 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.3 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.1 | 0.4 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 1.1 | GO:0032264 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 | 0.2 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.5 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.1 | 0.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.4 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.1 | 1.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.2 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 0.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.3 | GO:0070447 | regulation of cytokine activity(GO:0060300) positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.5 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.1 | 0.3 | GO:0060983 | epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) |
0.1 | 0.3 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 1.2 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 2.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.4 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.4 | GO:0060032 | notochord regression(GO:0060032) |
0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.8 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 1.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.3 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 2.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.3 | GO:0021893 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.1 | 0.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.5 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.1 | 3.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.4 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.1 | 0.3 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) lysosomal membrane organization(GO:0097212) |
0.1 | 0.4 | GO:1903756 | regulation of primitive erythrocyte differentiation(GO:0010725) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 1.1 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.4 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 1.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 1.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.3 | GO:2000449 | positive regulation of necrotic cell death(GO:0010940) CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.1 | 0.5 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.5 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 1.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 2.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 1.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.4 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.1 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.3 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 4.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.7 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.4 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.2 | GO:0034238 | macrophage fusion(GO:0034238) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.4 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.2 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.3 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.2 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.1 | 0.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.4 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.1 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.5 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.1 | 0.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.1 | 0.2 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 2.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.2 | GO:0034147 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) tolerance induction to lipopolysaccharide(GO:0072573) |
0.1 | 0.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 0.3 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 2.0 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.2 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.6 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.1 | 0.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 2.3 | GO:0032309 | icosanoid secretion(GO:0032309) |
0.1 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.2 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.1 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 1.1 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.1 | GO:0051309 | meiotic chromosome condensation(GO:0010032) female meiosis chromosome separation(GO:0051309) |
0.1 | 0.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 1.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 1.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 1.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.2 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.0 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 3.6 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.0 | 2.2 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.3 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.4 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 1.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 2.3 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.4 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.2 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.0 | 0.4 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.0 | 0.3 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
0.0 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.4 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 2.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.8 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 2.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.0 | 0.8 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.0 | 1.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.9 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 1.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 1.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 1.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.4 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.8 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.3 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:2001205 | TNFSF11-mediated signaling pathway(GO:0071847) negative regulation of bone development(GO:1903011) negative regulation of osteoclast development(GO:2001205) |
0.0 | 0.0 | GO:1903296 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.0 | 0.1 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.0 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 1.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 1.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.0 | 0.1 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
0.0 | 0.2 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.0 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:1905216 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.2 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.0 | 0.7 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.1 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.0 | 0.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.0 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 0.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.8 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.8 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 1.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.0 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.0 | 0.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.1 | GO:0089718 | amino acid import across plasma membrane(GO:0089718) L-glutamate import across plasma membrane(GO:0098712) |
0.0 | 0.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.1 | GO:1901906 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 0.7 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.1 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.1 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.4 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 1.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 2.2 | GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity(GO:0051091) |
0.0 | 0.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.0 | 1.0 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.6 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.0 | 0.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.4 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 0.3 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.0 | GO:1902915 | regulation of protein K63-linked ubiquitination(GO:1900044) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.1 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.0 | 0.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.0 | 0.4 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.4 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.7 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.0 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.0 | 0.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.2 | GO:0046033 | AMP metabolic process(GO:0046033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.6 | 4.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 3.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 2.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 1.8 | GO:0000802 | transverse filament(GO:0000802) |
0.4 | 1.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.4 | 1.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 1.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 1.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 2.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 2.5 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 3.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 2.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 2.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.4 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 2.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 0.7 | GO:0090537 | CERF complex(GO:0090537) |
0.2 | 0.9 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.2 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 3.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.5 | GO:0035101 | FACT complex(GO:0035101) |
0.2 | 0.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 1.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 0.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 7.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 1.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 2.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 2.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 1.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 0.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 0.3 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 2.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 1.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 1.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.1 | GO:0034448 | EGO complex(GO:0034448) |
0.1 | 2.1 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.9 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 2.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 2.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 1.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 2.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.5 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 1.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 1.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 3.8 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.3 | GO:0099522 | lysosomal lumen(GO:0043202) region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.1 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 2.1 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.3 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.1 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 2.2 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 2.1 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 4.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 2.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.0 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 1.9 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
0.0 | 0.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 1.6 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 2.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.3 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 1.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.3 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.6 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 1.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.1 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.0 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.0 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.4 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 1.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.8 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.0 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.6 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 1.6 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 1.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 1.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | GO:0004350 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.9 | 2.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.9 | 7.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.8 | 2.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.7 | 2.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.7 | 2.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 2.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.6 | 9.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.6 | 7.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 1.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 1.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 1.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.4 | 2.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 3.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 1.0 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.3 | 1.4 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.3 | 1.0 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.3 | 1.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 1.3 | GO:0031720 | haptoglobin binding(GO:0031720) hemoglobin alpha binding(GO:0031721) |
0.3 | 1.0 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.3 | 5.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 3.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 1.0 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
0.3 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 1.8 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 2.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 0.9 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.3 | 2.3 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.3 | 0.8 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.3 | 0.8 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.3 | 2.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 2.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 2.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.9 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 1.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 1.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 1.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 2.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 1.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 1.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 0.8 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.2 | 2.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 1.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.8 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.2 | 4.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 3.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.2 | 0.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 1.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 1.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.5 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.2 | 5.7 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 1.2 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 1.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 1.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.2 | 0.6 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 0.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.2 | 0.5 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 1.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 1.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 8.1 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 1.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.1 | 1.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.5 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.1 | 3.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 1.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 1.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 1.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.4 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.1 | 2.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 2.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 5.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.3 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 1.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 3.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 1.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.3 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.1 | 1.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.7 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 2.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 2.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 3.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 1.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 3.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.2 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.1 | 0.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 1.6 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.1 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.1 | 4.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 2.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.7 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 1.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 1.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 3.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.0 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 1.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.0 | 0.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.3 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.0 | 0.5 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.0 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.2 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.1 | GO:0036004 | GAF domain binding(GO:0036004) |
0.0 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.3 | GO:0031957 | fatty-acyl-CoA synthase activity(GO:0004321) very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.2 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) |
0.0 | 1.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 1.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:1902282 | phosphorelay sensor kinase activity(GO:0000155) voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.0 | 0.3 | GO:0008823 | ferric-chelate reductase activity(GO:0000293) cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 3.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 1.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 1.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 1.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 2.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 1.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 1.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 1.7 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 3.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 1.4 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.2 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.0 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 3.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.1 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.3 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.0 | 2.3 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 1.0 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 1.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 7.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 6.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 3.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 8.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 3.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 4.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 2.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 3.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 3.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 2.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 2.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 2.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 2.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.9 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 14.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 11.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 3.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.8 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 3.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 4.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 4.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 2.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 5.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 2.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 4.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.4 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 1.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 3.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 4.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.8 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 3.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.8 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 1.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 1.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 9.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 1.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 5.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.4 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 1.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 3.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 1.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.8 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 3.1 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 1.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 1.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 2.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |